Investments
3Portfolio Exits
1Expert Collections containing Wanger Asset Management
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Wanger Asset Management in 1 Expert Collection, including Pharma Startups.
Pharma Startups
5,090 items
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.
Wanger Asset Management Investments
3 Investments
Wanger Asset Management has made 3 investments. Their latest investment was in Syrrx as part of their Series D on December 12, 2001.
Wanger Asset Management Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
12/26/2001 | Series D | Syrrx | $18.5M | No | Alejandro Zaffaroni, Bay City Capital, Canadian Imperial Bank of Commerce, CMEA Capital, Cooper Hill Partners, HBM Partners, Invesco Global Health Science Fund, Jaspers, Joe Lewis, Lombard Odier, MPM Capital, and Versant Ventures | 1 |
9/7/2001 | Series C | |||||
1/1/2001 | Series C |
Date | 12/26/2001 | 9/7/2001 | 1/1/2001 |
|---|---|---|---|
Round | Series D | Series C | Series C |
Company | Syrrx | ||
Amount | $18.5M | ||
New? | No | ||
Co-Investors | Alejandro Zaffaroni, Bay City Capital, Canadian Imperial Bank of Commerce, CMEA Capital, Cooper Hill Partners, HBM Partners, Invesco Global Health Science Fund, Jaspers, Joe Lewis, Lombard Odier, MPM Capital, and Versant Ventures | ||
Sources | 1 |
Wanger Asset Management Portfolio Exits
1 Portfolio Exit
Wanger Asset Management has 1 portfolio exit. Their latest portfolio exit was Syrrx on February 07, 2005.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
2/7/2005 | Acquired | 1 |
Date | 2/7/2005 |
|---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 1 |